TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration by Wardhani BWK, Louisa M, Watanabe Y, Setiabudy R, Kato M

Get full text

TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel by Wardhani BWK, Puteri MU, Watanabe Y, Louisa M, Setiabudy R, Kato M

Get full text

Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia. by Sutanto, I, Endawati, D, Ling, L, Laihad, F, Setiabudy, R, Baird, J

Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia by Sutanto, I, Endawati, D, Hui Ling, L, Laihad, F, Setiabudy, R, Baird, J

Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia. by Sutanto, I, Tjahjono, B, Basri, H, Taylor, W, Putri, F, Meilia, R, Setiabudy, R, Nurleila, S, Ekawati, L, Elyazar, I, Farrar, J, Sudoyo, H, Baird, J

Association of impaired cytochrome P450 2D6 activity genotype and phenotype with therapeutic efficacy of primaquine treatment for latent Plasmodium vivax malaria by Baird, JK, Louisa, M, Noviyanti, R, Ekawati, L, Elyazar, I, Subekti, D, Chand, K, Gayatri, A, Instiaty, I, Soebianto, S, Crenna-Darusallam, C, Joko, D, Sulistyanto, BP, Meriyenes, D, Wesche, D, Nelwan, EJ, Sutanto, I, Sudoyo, H, Setiabudy, R